-
IMPACT OF COMORBIDITY BURDEN ON LONG-TERM QUALITY OF LIFE FOLLOWING SEVERE VIRAL LOWER RESPIRATORY TRACT DISEASE HOSPITALIZATION
Aug 11, 2026, 17:16 PM -
TWELVE-YEAR TRENDS IN DEPRESSIVE SYMPTOMS ACROSS SOCIOECONOMIC STRATA IN CHINESE ADULTS: A NATIONWIDE AGE-PERIOD-COHORT ANALYSIS
Aug 11, 2026, 17:16 PM -
DOES DKG-CERTIFICATION IMPROVE VALUE? A COST-EFFECTIVENESS ANALYSIS OF BREAST CANCER CARE USING CLAIMS DATA IN GERMANY
Aug 11, 2026, 17:16 PM -
DRIVERS OF NEGATIVE HTA DECISIONS IN BETWEEN ENGLAND AND IRELAND: A DATA-DRIVEN REVIEW OF COST-EFFECTIVENESS SUBMISSIONS
Aug 11, 2026, 17:16 PM -
INFORMATION AVAILABILITY AMONG THE 34 AUTHORITIES AND BODIES IN THE JCA SUBGROUP
Aug 11, 2026, 17:16 PM -
BEYOND THE REFERENCE CASE: EXTENDING A NICE PRECEDENT TO CONSIDER QUANTIFIABLE EFFECTS ON OTHER NHS PATIENTS
Aug 11, 2026, 17:16 PM -
INVESTIGATING THE CORRELATION BETWEEN PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN FIRST-LINE (1L) CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
Aug 11, 2026, 17:16 PM -
JOINT CLINICAL ASSESSMENTS AND THE CHALLENGE OF EVALUATING MEDICINES WITH NON-TRADITIONAL EVIDENCE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PEMBROLIZUMAB PLUS CHEMORADIOTHERAPY VERSUS CHEMORADIOTHERAPY ALONE FOR CERVICAL CANCER IN INDIA: A MARKOV MODEL EVALUATION
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF NON-CYSTIC FIBROSIS BRONCHIECTASIS IN EUROPE: EXACERBATIONS AND IMPLICATIONS FOR DISEASE PROGRESSION
Aug 11, 2026, 17:16 PM -
MODELING PATIENT TRAVEL IN ENVIRONMENTAL SUSTAINABILITY ASSESSMENTS OF CARE PATHWAYS: METHODOLOGICAL SOLUTIONS FOR DATA-SCARCE SETTINGS
Aug 11, 2026, 17:16 PM -
CARE PATHWAY FRAGMENTATION IN ALZHEIMER'S DISEASE: A QUALITATIVE MULTILEVEL ANALYSIS OF RESOURCE USE IMPLICATIONS IN MEXICO'S PUBLIC HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
KNOWLEDGE, ATTITUDES, AND DETERMINANTS OF RESPIRATORY SYNCYTIAL VIRUS VACCINATION AMONG PHYSICIANS AND OLDER ADULTS IN GREECE: A CROSS-SECTIONAL ONLINE SURVEY
Aug 11, 2026, 17:16 PM -
REVISED ASSESSMENT OF ATTACK-FREE OUTCOMES IN HEREDITARY ANGIOEDEMA: AN UPDATED NETWORK META-ANALYSIS OF PROPHYLACTIC TREATMENTS
Aug 11, 2026, 17:16 PM -
A SYSTEMATIC LITERATURE REVIEW OF HEALTH ECONOMIC MODELS FOR PAEDIATRIC MYOPIA
Aug 11, 2026, 17:16 PM -
REPLACING ASPARAGINASE WITH PEGASPARGASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: A PHARMACOECONOMIC ANALYSIS INTEGRATING DIRECT COSTS, LOGISTICAL BURDEN, AND CLINICAL OUTCOMES
Aug 11, 2026, 17:16 PM -
THE MERLIN ECOSYSTEM: AN INTEGRATED OPEN-SOURCE PLATFORM FOR SURVIVAL ANALYSIS, MULTI-STATE MODELING, AND HEALTH ECONOMIC EVALUATION IN R AND STATA
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF MYASTHENIA GRAVIS: SOCIETAL COST-OF-ILLNESS ASSESSMENT IN FRANCE
Aug 11, 2026, 17:16 PM -
LESSONS FROM TEN YEARS OF MEDICAL DEVICE ECONOMIC EVALUATIONS IN FRANCE: A REVIEW OF CEESP EFFICIENCY OPINIONS
Aug 11, 2026, 17:16 PM -
CLINICAL-ECONOMIC EVALUATION OF INTEGRATED STRATEGIES FOR SEVERE ASTHMA MANAGEMENT IN ITALY: A MULTIDIMENSIONAL PREDICTIVE APPROACH
Aug 11, 2026, 17:16 PM
